OTX Stock Overview
Medinex Limited, an investment holding company, provides professional support services to medical clinics in Singapore.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Medinex Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | S$0.20 |
52 Week High | S$0.22 |
52 Week Low | S$0.18 |
Beta | 0.16 |
1 Month Change | 9.89% |
3 Month Change | 9.89% |
1 Year Change | 2.56% |
3 Year Change | -4.76% |
5 Year Change | -31.03% |
Change since IPO | -28.57% |
Recent News & Updates
Recent updates
Shareholder Returns
OTX | SG Healthcare | SG Market | |
---|---|---|---|
7D | 11.7% | -1.7% | -1.7% |
1Y | 2.6% | -25.7% | -7.9% |
Return vs Industry: OTX exceeded the SG Healthcare industry which returned -25.7% over the past year.
Return vs Market: OTX exceeded the SG Market which returned -7.9% over the past year.
Price Volatility
OTX volatility | |
---|---|
OTX Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 6.6% |
Market Average Movement | 5.0% |
10% most volatile stocks in SG Market | 15.8% |
10% least volatile stocks in SG Market | 2.2% |
Stable Share Price: OTX has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine OTX's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 80 | Jessie Low | www.medinex.com.sg |
Medinex Limited, an investment holding company, provides professional support services to medical clinics in Singapore. The company operates through four segments: Medical Support Services, Business Support Services, Pharmaceutical Services, and Medical Services. The Medical Support Services segment engages in overseeing the setting up of clinics; and facilitating applications for relevant clinic licenses.
Medinex Limited Fundamentals Summary
OTX fundamental statistics | |
---|---|
Market cap | S$26.54m |
Earnings (TTM) | S$1.94m |
Revenue (TTM) | S$11.73m |
13.7x
P/E Ratio2.3x
P/S RatioIs OTX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
OTX income statement (TTM) | |
---|---|
Revenue | S$11.73m |
Cost of Revenue | S$8.45m |
Gross Profit | S$3.28m |
Other Expenses | S$1.34m |
Earnings | S$1.94m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.015 |
Gross Margin | 27.93% |
Net Profit Margin | 16.51% |
Debt/Equity Ratio | 8.9% |
How did OTX perform over the long term?
See historical performance and comparison